Group One Trading’s aTyr Pharma ATYR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$27.1K Sell
2,237
-1,235
-36% -$24K ﹤0.01% 5668
2026
Q2
$82.9K Sell
3,472
-1,128
-25% -$29.5K ﹤0.01% 5007
2026
Q1
$144K Sell
4,600
-176
-4% -$5.94K ﹤0.01% 4404
2025
Q4
$150K Buy
4,776
+4,345
+1,008% +$143K ﹤0.01% 4636
2025
Q3
$12.4K Sell
431
-1,338
-76% -$243K ﹤0.01% 7040
2025
Q2
$359K Sell
1,769
-473
-21% -$74.4K ﹤0.01% 3751
2025
Q1
$271K Buy
2,242
+2,061
+1,139% +$301K ﹤0.01% 3713
2024
Q4
$26.2K Buy
+181
New +$21.9K ﹤0.01% 5520
2022
Q4
– Sell
-362
Closed -$34.1K – 8233
2022
Q3
$43K Buy
362
+221
+157% +$29.6K ﹤0.01% 5529
2022
Q2
$16K Buy
+141
New +$20.4K ﹤0.01% 6478
2021
Q4
– Sell
-51
Closed -$17K – 8949
2021
Q3
$18K Buy
51
+50
+5,000% +$12K ﹤0.01% 7244
2021
Q2
$0 Hold
1
– – ﹤0.01% 8649
2021
Q1
$0 Hold
1
– – ﹤0.01% 8106
2020
Q4
$0 Hold
1
– – ﹤0.01% 7087
2020
Q3
$0 Hold
1
– – ﹤0.01% 6614
2020
Q2
$0 Hold
1
– – ﹤0.01% 6265
2020
Q1
$0 Hold
1
– – ﹤0.01% 5827
2019
Q4
$0 Hold
1
– – ﹤0.01% 5710
2019
Q3
$0 Hold
1
– – ﹤0.01% 5631
2019
Q2
$0 Buy
+1
New +$272 ﹤0.01% 5465
2019
Q1
– Hold
0
– – – 5456
2018
Q4
– Hold
0
– – – 5498
2018
Q3
– Hold
0
– – – 5677
2018
Q2
– Hold
0
– – – 5546

Other funds holding ATYR

Group One Trading's ATYR Position: Q3 2026 in Review

Group One Trading reduced its aTyr Pharma (ATYR) stake by 36% in Q3 2026, selling an estimated $24K and leaving 2,237 shares worth $27.1K. The position accounts for ﹤0.01% of the portfolio, ranked #5668.

Group One Trading first reported a position in ATYR in Q2 2019 and has held it in 20 quarters since. The position peaked at $359K in Q2 2025. 31 funds tracked by Wall St. Rank hold ATYR as of Q3 2026.

  • Group One Trading held 2,237 shares of aTyr Pharma worth $27.1K as of Q3 2026.
  • Group One Trading sold 1,235 aTyr Pharma shares in Q3 2026, an estimated $24K.
  • aTyr Pharma made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #5668 holding.
  • Group One Trading first reported a position in aTyr Pharma in Q2 2019 and has held it in 20 quarters since.
  • Group One Trading's aTyr Pharma position peaked at $359K in Q2 2025.
  • 31 funds tracked by Wall St. Rank held aTyr Pharma as of Q3 2026.

Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.